Developer docs
API playgroundTry for free, no card

Search company profiles

KÄÄPÄ Biotech

Full company profile

uuid0007clt

Namestring
KÄÄPÄ Biotech
Legal namestring
KÄÄPÄ Biotech
Company typeenum
Private
Founded yearint
2016
Descriptiontext

KÄÄPÄ Biotech is a privately held Finnish biotechnology company, founded in 2016 and headquartered in Karjalohja, Finland, that researches, develops, and supplies functional mushroom ingredients — specifically lion's mane, chaga, cordyceps, and reishi extracts — to the global nutraceutical and functional-food industries on a B2B basis. The company operates a vertically integrated production model spanning mushroom cultivation through proprietary extraction processes, with the explicit aim of controlling quality and consistency across the supply chain while supporting clinical research on the longevity and health benefits of its ingredients.

The company sells standardized functional mushroom extracts to nutraceutical manufacturers, dietary supplement brands, and functional food producers, using a quote-based B2B direct-sales model in which pricing is not publicly disclosed and contracts are negotiated per customer. Customer segmentation is concentrated on a single horizontal segment — nutraceutical/functional-food manufacturers — and there are no publicly disclosed customer logos, ARR figures, or revenue disclosures. The product surface is a focused four-ingredient portfolio rather than a broad SKU catalogue.

In November 2025, KÄÄPÄ Biotech closed a €9 million strategic investment co-led by PeakBridge and Zintinus, earmarked for increasing production capacity, improving extraction processes, expanding operations, and strengthening market position in the global functional mushroom ingredients market. The company states its ambition to set quality standards in the mushroom-based health product category, positioning itself as a supply-chain-controlled ingredient supplier rather than a finished consumer-goods brand.

Short descriptiontext

KÄÄPÄ Biotech is a Finnish biotech company that produces and supplies functional mushroom extract ingredients (lion's mane, chaga, cordyceps, reishi) on a B2B basis to nutraceutical manufacturers and functional food producers globally, using vertically integrated cultivation and extraction operations.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersKarjalohja, Finland
HQ citystring
Karjalohja
HQ countrystring
Finland
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
functional mushroom ingredients, mushroom extract supply, nutraceutical ingredient manufacturing, mycelium extraction processes, fungal biotech ingredients
Industry2 codes
PRIMARYAFAJAKAD
Botanical & Herbal Extracts (Adaptogens, Polyphenols, Essential Oils, Standardized Extracts)
Agriculture & Food Production/Food Ingredients & Additives/Nutraceutical & Functional Ingredients (Vitamins, Minerals, Omega-3s, Botanicals)
SECONDARYAFAGAHAK
Mushroom & Fungi Production (Indoor/Protected)
Agriculture & Food Production/Crop Farming/Greenhouse, Nursery & Floriculture Production (Protected Crops, Ornamentals, Seedlings)
NAICS code2 codes
  • Medicinal and Botanical Manufacturing325411
  • Spice and Extract Manufacturing311942
SIC code2 codes
  • Medicinal Chemicals & Botanical Products2833
  • Food And Kindred Products2000
Product category
Nutraceutical Ingredients
No data
Revenue model1 record
1Functional Mushroom Ingredients B2B Sales
TypeOne Time License
Description

Sale of functional mushroom ingredients (lion's mane, chaga, cordyceps, reishi) to nutraceutical manufacturers and brands in the global market. Revenue generated through bulk ingredient supply to B2B customers in the health product sector.

kaapabiotech.com
Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Supply Chain, Technology or R&D, Infrastructure
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

KÄÄPÄ Biotech produces and supplies functional mushroom ingredient extracts — including lion's mane, chaga, cordyceps, and reishi — through vertically integrated cultivation and proprietary extraction processes. The company sells these standardized mushroom extracts on a B2B basis to nutraceutical manufacturers, dietary supplement brands, and functional food producers in the global market.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

KÄÄPÄ Biotech is a Finnish biotech company operating in the functional mushroom ingredients sector, supplying B2B ingredients (lion's mane, chaga, cordyceps, and reishi extracts) to the global nutraceutical and health product markets. The company focuses on vertical integration, improved extraction processes, and clinical research on longevity benefits. Funded by a €9 million strategic investment from PeakBridge and Zintinus in November 2025 to expand production capacity and market position.

Product and service5 records
1Functional Mushroom Ingredients
CategoryNutraceutical Ingredients
Description

KÄÄPÄ Biotech's overarching offering: functional mushroom ingredient extracts (lion's mane, chaga, cordyceps, reishi) supplied to nutraceutical and health product manufacturers on a B2B basis. Produced through vertically integrated cultivation and proprietary extraction processes.

2Lion's Mane Extract
CategoryNutraceutical Ingredients
Description

Functional mushroom ingredient extract derived from lion's mane, supplied to nutraceutical manufacturers for use in dietary supplement and functional health product formulations.

3Chaga Extract
CategoryNutraceutical Ingredients
Description

Functional mushroom ingredient extract derived from chaga, supplied to nutraceutical manufacturers for use in dietary supplement and functional health product formulations.

4Cordyceps Extract
CategoryNutraceutical Ingredients
Description

Functional mushroom ingredient extract derived from cordyceps, supplied to nutraceutical manufacturers for use in dietary supplement and functional health product formulations.

5Reishi Extract
CategoryNutraceutical Ingredients
Description

Functional mushroom ingredient extract derived from reishi, supplied to nutraceutical manufacturers for use in dietary supplement and functional health product formulations.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers9 records
TypeDirect peer
Description

Nammex is a North American supplier of organic mushroom extracts for the supplement industry, offering fruiting-body extracts of reishi, lion's mane, cordyceps, and chaga. It is the closest direct competitor to KÄÄPÄ in B2B functional mushroom ingredients, with comparable product breadth, B2B model, and premium quality positioning.

TypeDirect peer
Description

M2 Ingredients supplies organic, whole-food mushroom powders and extracts for functional food and supplement brands. It is a direct peer to KÄÄPÄ, serving the same B2B nutraceutical customers with similar functional mushroom species and a comparable emphasis on quality and traceability.

TypeDirect peer
Description

Real Mushroom supplies 100% mushroom-fruiting-body extracts to supplement and functional food manufacturers globally. It directly competes with KÄÄPÄ in the premium B2B extract category, with overlapping species portfolio and a similar quality-differentiation narrative.

TypeDirect peer
Description

Hifas da Terra is a Spanish biotech company that develops and produces functional mushroom extracts for nutraceutical and clinical applications. Comparable to KÄÄPÄ in vertical integration, European base, and B2B focus on therapeutic-grade mushroom ingredients.

TypeEmerging player
Description

MycoTechnology is a US-based fermentation and mycelium-ingredient company developing protein and functional ingredients using fungal platforms. Adjacent to KÄÄPÄ in biotechnology approach and B2B ingredient supply, though focused more on food protein than nutraceutical extracts.

TypeRegional player
Description

Life Cykel is an Australian functional mushroom company producing extracts and ingredients from upcycled coffee waste substrates. It is comparable to KÄÄPÄ in functional mushroom extracts and B2B nutraceutical supply, though primarily serving the Australian and APAC markets.

TypeBroad incumbent
Description

Four Sigmatic is a global functional mushroom brand selling mushroom coffee, elixirs, and supplements direct-to-consumer. It operates in the same functional mushroom category as KÄÄPÄ but is downstream (B2C brand) rather than upstream B2B ingredient supplier, making it an adjacent incumbent rather than direct competitor.

TypeBroad incumbent
Description

Fungi Perfecti, founded by Paul Stamets, produces and sells Host Defense mushroom supplements and related functional mushroom products. Comparable to KÄÄPÄ in the functional mushroom category and cultivation expertise, but focused on finished B2C supplement products rather than B2B ingredient supply.

TypeBroad incumbent
Description

Layn Natural Ingredients is a global supplier of botanical extracts, including functional mushroom extracts, to food, beverage, and nutraceutical manufacturers. It overlaps with KÄÄPÄ in plant-based extract manufacturing and B2B nutraceutical supply but operates across a much broader botanical portfolio.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks3 records

Each record includes

Headline, Details, Source

Key highlights1 record

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles3 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds2 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors2 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment1 record

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

KÄÄPÄ Biotech

Nutraceutical Ingredientskaapabiotech.com

KÄÄPÄ Biotech is a Finnish biotech company that produces and supplies functional mushroom extract ingredients (lion's mane, chaga, cordyceps, reishi) on a B2B basis to nutraceutical manufacturers and functional food producers globally, using vertically integrated cultivation and extraction operations.

What KÄÄPÄ Biotech does

KÄÄPÄ Biotech is a privately held Finnish biotechnology company, founded in 2016 and headquartered in Karjalohja, Finland, that researches, develops, and supplies functional mushroom ingredients — specifically lion's mane, chaga, cordyceps, and reishi extracts — to the global nutraceutical and functional-food industries on a B2B basis. The company operates a vertically integrated production model spanning mushroom cultivation through proprietary extraction processes, with the explicit aim of controlling quality and consistency across the supply chain while supporting clinical research on the longevity and health benefits of its ingredients.

The company sells standardized functional mushroom extracts to nutraceutical manufacturers, dietary supplement brands, and functional food producers, using a quote-based B2B direct-sales model in which pricing is not publicly disclosed and contracts are negotiated per customer. Customer segmentation is concentrated on a single horizontal segment — nutraceutical/functional-food manufacturers — and there are no publicly disclosed customer logos, ARR figures, or revenue disclosures. The product surface is a focused four-ingredient portfolio rather than a broad SKU catalogue.

In November 2025, KÄÄPÄ Biotech closed a €9 million strategic investment co-led by PeakBridge and Zintinus, earmarked for increasing production capacity, improving extraction processes, expanding operations, and strengthening market position in the global functional mushroom ingredients market. The company states its ambition to set quality standards in the mushroom-based health product category, positioning itself as a supply-chain-controlled ingredient supplier rather than a finished consumer-goods brand.

KÄÄPÄ Biotech firmographics

Firmographics
Name
KÄÄPÄ Biotech
Legal name
KÄÄPÄ Biotech
Website
https://kaapabiotech.com
Company type
Private
Founded year
2016
Operating status
Operating
Headcount range
11–50 employees
Short description
KÄÄPÄ Biotech is a Finnish biotech company that produces and supplies functional mushroom extract ingredients (lion's mane, chaga, cordyceps, reishi) on a B2B basis to nutraceutical manufacturers and functional food producers globally, using vertically integrated cultivation and extraction operations.
Ownership category
akta.pro rank

KÄÄPÄ Biotech industry classification

Industry
Product category
Nutraceutical Ingredients
NAICS
Medicinal and Botanical Manufacturing (325411), Spice and Extract Manufacturing (311942)
SIC
Medicinal Chemicals & Botanical Products (2833), Food And Kindred Products (2000)
akta.pro industry
PRIMARYAFAJAKAD
Botanical & Herbal Extracts (Adaptogens, Polyphenols, Essential Oils, Standardized Extracts)
Agriculture & Food Production/Food Ingredients & Additives/Nutraceutical & Functional Ingredients (Vitamins, Minerals, Omega-3s, Botanicals)
SECONDARYAFAGAHAK
Mushroom & Fungi Production (Indoor/Protected)
Agriculture & Food Production/Crop Farming/Greenhouse, Nursery & Floriculture Production (Protected Crops, Ornamentals, Seedlings)

Keywords

  • Functional mushroom ingredients
  • Mushroom extract supply
  • Nutraceutical ingredient manufacturing
  • Mycelium extraction processes
  • Fungal biotech ingredients

Where KÄÄPÄ Biotech is headquartered

Location

Headquarters

HQ city
Karjalohja
HQ country
Finland
HQ region
Europe

Offices1 record

Markets served

KÄÄPÄ Biotech business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Operations, Supply Chain, Technology or R&D, Infrastructure

Revenue model

  1. Functional Mushroom Ingredients B2B Sales: Sale of functional mushroom ingredients (lion's mane, chaga, cordyceps, reishi) to nutraceutical manufacturers and brands in the global market. Revenue generated through bulk ingredient supply to B2B customers in the health product sector.

Distribution channels1 record

KÄÄPÄ Biotech product offering

Product offering

Core offering

KÄÄPÄ Biotech produces and supplies functional mushroom ingredient extracts — including lion's mane, chaga, cordyceps, and reishi — through vertically integrated cultivation and proprietary extraction processes. The company sells these standardized mushroom extracts on a B2B basis to nutraceutical manufacturers, dietary supplement brands, and functional food producers in the global market.

Product overview

KÄÄPÄ Biotech is a Finnish biotech company operating in the functional mushroom ingredients sector, supplying B2B ingredients (lion's mane, chaga, cordyceps, and reishi extracts) to the global nutraceutical and health product markets. The company focuses on vertical integration, improved extraction processes, and clinical research on longevity benefits. Funded by a €9 million strategic investment from PeakBridge and Zintinus in November 2025 to expand production capacity and market position.

Differentiator

Problem solved

Functional benefit

Products and services

  • Functional Mushroom Ingredients KÄÄPÄ Biotech's overarching offering: functional mushroom ingredient extracts (lion's mane, chaga, cordyceps, reishi) supplied to nutraceutical and health product manufacturers on a B2B basis. Produced through vertically integrated cultivation and proprietary extraction processes.
  • Lion's Mane Extract Functional mushroom ingredient extract derived from lion's mane, supplied to nutraceutical manufacturers for use in dietary supplement and functional health product formulations.
  • Chaga Extract Functional mushroom ingredient extract derived from chaga, supplied to nutraceutical manufacturers for use in dietary supplement and functional health product formulations.
  • Cordyceps Extract Functional mushroom ingredient extract derived from cordyceps, supplied to nutraceutical manufacturers for use in dietary supplement and functional health product formulations.
  • Reishi Extract Functional mushroom ingredient extract derived from reishi, supplied to nutraceutical manufacturers for use in dietary supplement and functional health product formulations.

Companies that use KÄÄPÄ Biotech

Customer profile

Segments1 record

Ideal customer profiles1 record

KÄÄPÄ Biotech technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

KÄÄPÄ Biotech partnerships and signals

Strategic signal

Scale indicators3 records

Recent moves5 records

Expansion highlights5 records

KÄÄPÄ Biotech competitors and assessment

Company assessment

Direct peers

  • Nammex: Nammex is a North American supplier of organic mushroom extracts for the supplement industry, offering fruiting-body extracts of reishi, lion's mane, cordyceps, and chaga. It is the closest direct competitor to KÄÄPÄ in B2B functional mushroom ingredients, with comparable product breadth, B2B model, and premium quality positioning.
  • M2 Ingredients: M2 Ingredients supplies organic, whole-food mushroom powders and extracts for functional food and supplement brands. It is a direct peer to KÄÄPÄ, serving the same B2B nutraceutical customers with similar functional mushroom species and a comparable emphasis on quality and traceability.
  • Real Mushroom: Real Mushroom supplies 100% mushroom-fruiting-body extracts to supplement and functional food manufacturers globally. It directly competes with KÄÄPÄ in the premium B2B extract category, with overlapping species portfolio and a similar quality-differentiation narrative.
  • Hifas da Terra: Hifas da Terra is a Spanish biotech company that develops and produces functional mushroom extracts for nutraceutical and clinical applications. Comparable to KÄÄPÄ in vertical integration, European base, and B2B focus on therapeutic-grade mushroom ingredients.

Emerging players

  • MycoTechnology: MycoTechnology is a US-based fermentation and mycelium-ingredient company developing protein and functional ingredients using fungal platforms. Adjacent to KÄÄPÄ in biotechnology approach and B2B ingredient supply, though focused more on food protein than nutraceutical extracts.

Regional players

  • Life Cykel: Life Cykel is an Australian functional mushroom company producing extracts and ingredients from upcycled coffee waste substrates. It is comparable to KÄÄPÄ in functional mushroom extracts and B2B nutraceutical supply, though primarily serving the Australian and APAC markets.

Broad incumbents

  • Four Sigmatic: Four Sigmatic is a global functional mushroom brand selling mushroom coffee, elixirs, and supplements direct-to-consumer. It operates in the same functional mushroom category as KÄÄPÄ but is downstream (B2C brand) rather than upstream B2B ingredient supplier, making it an adjacent incumbent rather than direct competitor.
  • Fungi Perfecti (Host Defense): Fungi Perfecti, founded by Paul Stamets, produces and sells Host Defense mushroom supplements and related functional mushroom products. Comparable to KÄÄPÄ in the functional mushroom category and cultivation expertise, but focused on finished B2C supplement products rather than B2B ingredient supply.
  • Layn Natural Ingredients: Layn Natural Ingredients is a global supplier of botanical extracts, including functional mushroom extracts, to food, beverage, and nutraceutical manufacturers. It overlaps with KÄÄPÄ in plant-based extract manufacturing and B2B nutraceutical supply but operates across a much broader botanical portfolio.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks3 records

Key highlights1 record

Customer concentration

KÄÄPÄ Biotech financial estimates

Financial estimate

Revenue estimate

Valuation estimate

KÄÄPÄ Biotech leadership team

Management profile

Number of profiles

Profiles3 records

KÄÄPÄ Biotech funding detail

Funding detail

Funding overview

Funding rounds2 records

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

KÄÄPÄ Biotech M&A and investment

M&A and investment

M&A

Investments1 record

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about KÄÄPÄ Biotech

What does KÄÄPÄ Biotech do?

KÄÄPÄ Biotech produces and supplies functional mushroom ingredient extracts — including lion's mane, chaga, cordyceps, and reishi — through vertically integrated cultivation and proprietary extraction processes. The company sells these standardized mushroom extracts on a B2B basis to nutraceutical manufacturers, dietary supplement brands, and functional food producers in the global market.

Is KÄÄPÄ Biotech a public or private company?

KÄÄPÄ Biotech is a private company. It is classified as venture growth investor backed and is currently operating.

When was KÄÄPÄ Biotech founded?

KÄÄPÄ Biotech was founded in 2016. It employs 11 to 50 people.

Where is KÄÄPÄ Biotech based?

KÄÄPÄ Biotech is headquartered in Karjalohja, Finland, in the Europe region.

How does KÄÄPÄ Biotech make money?

One revenue line is on record: functional Mushroom Ingredients B2B Sales.

Who are KÄÄPÄ Biotech's main competitors?

Direct peers on record are Nammex, M2 Ingredients, Real Mushroom and Hifas da Terra. MycoTechnology is listed as an emerging player. Life Cykel is listed as a regional player. Broad incumbents are Four Sigmatic, Fungi Perfecti (Host Defense) and Layn Natural Ingredients.

Does KÄÄPÄ Biotech have an API?

No public API is recorded for KÄÄPÄ Biotech.

What industry is KÄÄPÄ Biotech in?

KÄÄPÄ Biotech's product category is Nutraceutical Ingredients. Its primary akta.pro industry code is AFAJAKAD, Botanical & Herbal Extracts (Adaptogens, Polyphenols, Essential Oils, Standardized Extracts), with a secondary code of AFAGAHAK, Mushroom & Fungi Production (Indoor/Protected). Its NAICS code is 325411 and its SIC code is 2833.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Longevity.TechnologyFinnish biotech lands funding to ramp production of ‘functional mushrooms’Finland-based KAAPA Biotech has secured €9 million in funding from investors PeakBridge and Zintinus to advance its development and production of functional mushroom ingredients for the wellness, nutrition and supplement industries. The capital will fund expansion of new cultivation facilities in Paimio and Salo, strengthen vertical integration from cultivation to extraction, and accelerate clinical research on chaga and other functional mushroom species. The company aims to establish quality and purity standards for the functional mushroom market through proprietary extraction processes that ensure high-purity extracts with consistent batch-to-batch potency.GlobeNewswireApplied Food Sciences and KÄÄPÄ Biotech Expand Partnership with New State-of-the-Art Cultivation FacilityApplied Food Sciences and KÄÄPÄ Biotech opened a new cultivation facility in Finland to expand their partnership. The facility supports cultivation of premium functional mushrooms, including Lion's Mane, Reishi, and others, to meet rising global demand. The expansion aims to increase production efficiency and product quality.GlobeNewswireApplied Food Sciences Partners With KÄÄPÄ Biotech to Launch Organic Nordic Mushroom ExtractsApplied Food Sciences announced an equity investment and partnership with Finnish KÄÄPÄ Biotech to supply organic Nordic mushroom extracts. The partnership adds six powdered extracts—Lion's Mane, Reishi, Cordyceps, Chaga, Shiitake, and Maitake—to AFS' botanical portfolio. The extracts are USDA-certified organic, GRAS, and third-party tested for purity.GlobeNewswireApplied Food Sciences Partners With KÄÄPÄ Biotech to Launch Organic Nordic Mushroom ExtractsApplied Food Sciences announced an equity investment and partnership with Finnish KÄÄPÄ Biotech to supply organic Nordic mushroom extracts. The partnership adds six powdered extracts—Lion's Mane, Reishi, Cordyceps, Chaga, Shiitake, and Maitake—to AFS' botanical portfolio. The extracts are USDA-certified organic, GRAS, and third-party tested for purity.